openPR Logo
Press release

Cancer/Tumor Profiling Market : Overview with Detailed Analysis, Competitive landscape Forecast to 2019

09-03-2018 12:38 PM CET | Health & Medicine

Press release from: Transparency Market Research 

Cancer/Tumor Profiling Market : Overview with Detailed

Global Cancer/Tumor Profiling Market: Overview

With more than 14 million new cases and over 8.2 million deaths (U.S. National Cancer Institute) directly related to complications led by the disease, cancer has become one of the leading socioeconomic burdens and most prevalent cause of deaths across the globe. The WHO states that the disease will lead to the death of over 11.5 million people by 2030 across the globe. The alarmingly rising prevalence of the disease has driven vast research and development activities in the field of cancer diagnosis and treatment in the past few years.

View Report: https://www.transparencymarketresearch.com/cancer-tumor-profiling.html

The field of cancer diagnosis has significantly evolved and a number of ways, including medical imaging and screening tests, are being increasingly used for diagnosing the onset or the growth of the tumor tissue. In present times, tumor profiling is also increasingly undertaken to allow the physician a better understanding of the patient’s genomic alterations and cancer profile to decide on a suitable course of therapy. Cancer/tumor profiling is also undertaken to rule out a therapy that is unlikely to provide successful outcomes, thus reducing the time, energy, and money spent in the trial and error approach.

Global Cancer/Tumor Profiling Market: Drivers and Restraints

The global market for cancer/tumor profiling is expected to witness expansion at a significant pace in the next few years, chiefly owing to the rising funds being directed towards activities aimed at improving the overall course of diagnosis and treatment of the disease and vast technological advancements recently observed in the field of tumor profiling. The market is also driven by the rising adoption of point of care diagnostics and the resultant rise in demand for personalized medicines.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2395

The continuously rising socioeconomic burden of cancer and the pressure on the healthcare industry to present effective methods of tackling and managing the condition are also driving the market for cancer/tumor profiling. However, the added expenditure that profiling procedures require could hinder their adoption to a certain extent, limiting the scope of these procedures to high-income regions. Nevertheless, rising government intervention and pouring funds from public and private institutions towards the diagnosis and treatment of cancer are expected to allow the market achieve promising growth avenues.

Global Cancer/Tumor Profiling Market: Geographical and Competitive Landscape

It is estimated that over 60% of the world’s new cancer cases occur in regions such as Asia, Africa, and South and Central America; 70% of the world’s deaths due to cancer also occur in these regions. Pointing to a huge patient pool and potential consumers, these regions could be the leading contributors to the growth and development of the global cancer/tumor profiling market. It is, however, developed regions with high disposable incomes such as North America and Europe that presently lead the market.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2395

Apart from the rising pool of cancer patients in these regions, the market for cancer/tumor profiling also thrives owing to technologically advanced healthcare infrastructures, availability of advanced research and development facilities, and the presence of a vast number of technology providers. Over the report’s forecast period as well, these regions will continue to remain the leading contributors of revenue to the global market. The market in developing economies across promising regional markets such as South and Central America and Asia Pacific will expand owing to rising purchasing powers of the population and promising development of healthcare infrastructures.

Some of the leading vendors operating in the global market for cancer/tumor profiling are Caris Life Sciences, Genomic Health, Inc., Life Technologies Corporation, Boreal Genomics, Inc., Ribomed Biotechnologies, Oxford Gene Technology Ltd., Illumina, Inc., Oncopath Laboratory, Precision Therapeutics, Inc., Neogenomics Laboratories, Precision Therapeutics, Inc., and Nanostring Technologies.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer/Tumor Profiling Market : Overview with Detailed Analysis, Competitive landscape Forecast to 2019 here

News-ID: 1216430 • Views: 138

More Releases from Transparency Market Research 

Image Guided Surgery Devices Market Analysis and Research Report by Experts 2025
The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing
Laboratory Centrifuge Market Growth, Trends and Demands Research Report and Fore …
The players in the worldwide laboratory centrifuge market are concentrating on item launch with a technological distinction. The focused scene is broadly divided because of solid emergence of a few players. Organizations are likewise foreseen that they would concentrate on clinical trials, joint ventures, research and development, mergers, and acquisitions to stay in ahead of the opposition. A portion of the main players in the worldwide laboratory centrifuge market are
Surgical Drapes Market Competitive Strategies, Regional Analysis Forecast 2024
The global surgical drapes market exhibit the presence of several tier 1, tier 2, and tier 3 companies. This is indicative of a highly competitive vendor landscape. According to a new study by Transparency Market Research (TMR), some of the prominent companies operating in the global surgical drapes market have resorted to strategies such as product differentiation, aggressive pricing, and product upgrades to buoy competitive strength. Besides these, several companies
Heparin Market Precise Analysis on Business Overview, Product Scope And Ongoing …
The global heparin market is expected to become progressively competitive over the forthcoming years. This is due to the strengthening position of the leading market players in the global market for heparin. Several initiatives have been taken by the leading market players to retain their strong foothold over the market. Intensive research and development along with effective marketing hacks have been the key highlights of the business strategy of the

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and